Koyfin Home > Directory > Health Care > Antares Pharma > Net Debt / EBITDA

Antares Pharma Net Debt / EBITDA Chart (ATRS)

Antares Pharma annual/quarterly Net Debt / EBITDA from 2010 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Antares Pharma Net Debt / EBITDA for the quarter ending June 06, 2020 was $0m a 201.57% decrease of -1m year over year
  • Antares Pharma Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $0m a -71.97% increase of 0m year over year
  • Antares Pharma Annual Net Debt / EBITDA for 2019 was $0m a 27.81% increase of 0m from 2018
  • Antares Pharma Annual Net Debt / EBITDA for 2018 was $0m a -134.19% decrease of 0m from 2017
  • Antares Pharma Annual Net Debt / EBITDA for 2017 was $0m a -166.78% decrease of -1m from 2016
Other Ratios Metrics:
  • Antares Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $39m a -19.64% decrease of -8m year over year
  • Antares Pharma Other Liabilities for the quarter ending September 09, 2018 was $0m a 0.00% decrease of 0m year over year
  • Antares Pharma Total Debt / Equity for the quarter ending December 12, 2018 was $64m a -36.97% decrease of -24m year over year
View Chart On Koyfin

Quarterly ATRS Net Debt / EBITDA Data

06/2020$0m
03/2020$2m
12/2019$0m
09/2019$0m
06/2019$-1m
03/2019$0m
12/2018$0m
09/2018$1m
06/2018$0m
03/2018$0m

Annual ATRS Net Debt / EBITDA Data

2019$0m
2018$0m
2017$0m
2016$1m
2015$3m
2014$1m
2013$3m
2012$7m
2011$7m
2010$2m